Federal prosecutors say Joshua Bradley took prescription stimulants intended for pharmacy customers on five occasions in 2024. His sentencing is set for December.
Pittsfield Pharmacist Admits to Misusing Prescription Drugs
BOSTON — A Pittsfield pharmacist pleaded guilty to taking prescription drugs intended for customers while working at a national pharmacy chain, federal prosecutors said. Joshua Bradley, 30, admitted to five counts of acquiring a controlled substance by fraud, deception and subterfuge. His guilty plea came in federal court in Boston on Sept. 17, 2026. A judge scheduled sentencing for Dec. 15.
This case highlights the serious issue of prescription drug misuse, particularly the case where the Pittsfield Pharmacist Admits to Misusing Prescription Drugs, bringing attention to the need for strict adherence to pharmaceutical regulations.
The case concerns Adderall and dextroamphetamine, a generic form of the medication. Prosecutors say Bradley diverted the drugs for his own use in 2024. The U.S. Attorney’s Office for the District of Massachusetts announced the plea on Sept. 18.
What Bradley admitted
According to federal prosecutors, Bradley worked as a licensed pharmacist at an unnamed national pharmacy chain. He took various quantities of dextroamphetamine for his own use on four occasions across August, September and November 2024. Prosecutors also say he took Adderall on Nov. 10, 2024.
The medication was originally intended for customers. Prosecutors did not identify the chain, the pharmacy location, the customers involved or the total number of pills in the public announcement. The release also did not say whether any customer received a delayed or altered prescription. Those details should not be assumed from the plea announcement.
Bradley pleaded guilty to five federal counts. The government describes the offense as acquiring a controlled substance through “fraud, deception and subterfuge.” He had been charged in July 2026, according to the Justice Department.
What happens next
U.S. Senior District Judge William G. Young scheduled Bradley’s sentencing for Dec. 15, 2026. A guilty plea resolves the question of whether Bradley admitted the charged conduct; it does not establish what sentence he will receive.
Federal prosecutors say the charge carries a maximum penalty of four years in prison, one year of supervised release and a $250,000 fine. Those are statutory possibilities, not a sentence already imposed. The judge will determine the outcome under the law and federal sentencing guidelines.
Key points in the case:
- Defendant: Joshua Bradley, 30, of Pittsfield, Massachusetts.
- Plea: Guilty to five counts of acquiring a controlled substance by fraud, deception and subterfuge.
- Drugs: Dextroamphetamine and Adderall intended for customers.
- Period: Four diversions of dextroamphetamine in August, September and November 2024, plus an Adderall diversion on Nov. 10, 2024.
- Next court date: Sentencing scheduled for Dec. 15, 2026.
Why diversion matters
Prescription drug diversion means a medication is taken or redirected away from the person or lawful purpose for which it was intended. In this case, the government’s account says a pharmacist took controlled prescription stimulants that were meant for customers.
Pharmacists hold a position of trust. Patients rely on them to fill prescriptions accurately and safeguard medications. That makes an admitted diversion by a licensed pharmacist a public-interest story, even though prosecutors have not described an individual patient’s experience in this case.
There is also a limit to what the available record establishes. The Justice Department’s short announcement identifies the admitted conduct and the planned sentencing date, but gives no account of how the diversions were discovered. It does not name Bradley’s employer or describe any action by a pharmacy licensing board. The public should distinguish those unanswered questions from the facts of the plea.
A federal case in Massachusetts
The U.S. Attorney’s Office and the Drug Enforcement Administration’s New England Field Division announced the case. The Justice Department credited Massachusetts State Police, the Barnstable County Sheriff’s Department and several Cape Cod police departments with assistance. Assistant U.S. Attorney Meghan Cleary of the Health Care Fraud Unit is prosecuting it.
Bradley lives in Pittsfield, in Berkshire County, and entered his plea in Boston. Federal officials have not reported a connection between this case and a pharmacy or patient in the Utica area. The case remains relevant as an example of the safeguards customers expect when a pharmacy handles controlled medication, but its local effects should not be overstated.
The next confirmed milestone is the Dec. 15 sentencing hearing. Readers can follow updates through the Justice Department’s case announcement. Anyone concerned about a specific prescription should contact their pharmacist or prescriber to check their own records rather than assume this case affected their medication.
Source: U.S. Attorney’s Office, District of Massachusetts, Sept. 18, 2026; DEA charging announcement, Sept. 9, 2026.
